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Summary
Objective: To determine the expression profile of protein kinase (PK) and protein tyrosine kinase (PTK) genes in human primary osteoarthritis
(OA) chondrocytes and to compare it with that of immortalized human chondrocytes T/C 28a4 with a view to learning whether T/C 28a4 cells
can be used for elucidating signal transduction pathways in human chondrocytes.
Design: We used the Atlas Human cDNA Array and a method based on PCR with degenerate primers to analyse the expression profile of
protein kinase genes in primary human OA chondrocytes and compared it with that of immortalized human chondrocyte cell line T/C 28a4
using RT-PCR and Western blotting.
Results: A total of 21 PTK genes were identified and several of these have never been shown to be expressed in human OA chondrocytes.
Comparative expression analysis of some selected kinase genes showed that the mRNA expression pattern of many protein kinase genes
in OA chondrocytes was identical to that of T/C 28a4 cells. However, there were differences in the level of protein expression of selected
protein kinases in these cells. For example, mRNA expression of the novel kinase HCK was detected in OA chondrocytes and in the cell lines
analysed but by Western blotting HCK protein was not detected in OA chondrocytes. In these studies, we also identified a novel mutant form
of the discoidin domain receptor 2 (DDR2) transcript from chondrocyte-like cell line HTB-94.
Conclusions: Our results provide novel information about protein kinase gene expression in OA chondrocytes and indicate that the
transformed chondrocyte cell line T/C 28a4 may be suitable for elucidating signal transduction pathways in chondrocytes and to investigate
how they regulate chondrocyte function in inflammatory and degenerative joint diseases. © 2001 OsteoArthritis Research Society
International
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It is now well known that co-ordination of most of the
signals required for the development of the cellular
response to injury or other external stimuli is dependent on
a reversible protein phosphorylation mechanism1–3 cata-
lyzed by a group of enzymes termed protein tyrosine
kinases (PTKs). The PTKs are categorized into two
classes: (a) receptor kinases are those PTKs linked to
receptors for growth factors [e.g. epidermal growth factor
receptor (EGFR)]; and (b) non-receptor PTKs (e.g. Lck).
Signaling is initiated by ligand binding and the signal
transduced and executed by tyrosine phosphorylation of
assembled proteins containing the src homology two
domains (SH2) (reviewed in Cadena and Gill4 and
Courtneidge5). The accumulated evidence suggests that
PTKs physically interact with one another and that the
phosphorylated sequences associate with SH2 domains
which serves to regulate protein/protein interactions
(Courtneidge5 and references therein). Among the PTKs684family, c-erbB/EGFR is the one most frequently implicated
in human diseases as it plays an important role in the
regulation of cell behavior and can elicit a broad spectrum
of cellular responses including the expression of various
mediators of inflammation, adhesion molecules, matrix
proteins and metalloproteinases5–7), all of which could
contribute to the progression of inflammatory and degen-
erative joint diseases such as rheumatoid arthritis (RA) and
osteoarthritis (OA), respectively.
PTK-mediated signaling pathways are also required for
normal cartilage and growth plate development indicating
that specific PTKs may be essential for maintaining the
chondrocyte lineage8. For example, it has been demon-
strated that Sox9—a high mobility-group domain-
containing transcription factor—is essential for chondrocyte
differentiation and cartilage formation9. Sox9 is stimulated
by fibroblast growth factors (FGFs) and this regulation is
mediated by mitogen-activated protein kinase (MAPK)
pathway indicating that MAPK plays an important role in
chondrogenesis10. Regulation of chondrocytes by trans-
forming growth factor-beta (TGF-) occurs via activation of
two different, but interacting, signaling cascades, that
involve protein kinases11 and activation of a specific MAPK
kinase (MEK/ERK, MAPKK) cascade is necessary for
TGF- signaling in chondrocytes12. Chondrocytes from
aging rats were found to respond poorly to insulin-like
growth factor-1 (IGF-1) and this defect in their response to
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CELL LINES AND HUMAN OA CHONDROCYTES
We recently characterized the human chondrosar-
coma cell line HTB-9418. The immortalized human
chondrocytic cell line T/C 28a419 was kindly provided by Dr
Mary B. Goldring (New England Baptist Bone and Joint
Institute, Harvard Institutes of Medicine, Boston, MA).
Osteosarcoma cell lines SAOS-2 and U2-OS were from
ATCC (Manassas, VA). Cells were expanded in Dulbecco’smodified Eagle medium (DMEM) /Hams F-12 medium
(50:50) supplemented with 10% fetal bovine serum,
L-glutamine, penicillin-streptomycin, and Fungizone (all
from GIBCO-BRL, Gaithersburg, MD) and grown in humidi-
fied air with 5% CO2 at 37°C. Human OA chondro-
cytes were prepared from ‘resident’ osteoarthritic cartilage
following joint replacement surgery by enzymatic digestion
as previously described18 and either primary or single
passage chondrocytes were employed for these studies.PREPARATION OF mRNA, HYBRIDIZATION AND SCREENING OF
ATLAS HUMAN CDNA EXPRESSION ARRAY
At 80–90% confluence, chondrocytes were collected by
scraping, washed twice with PBS and used for the prep-
aration of mRNA with a commercially available kit (Fast-
Track, InVitrogen, San Diego, CA) according to the
instructions provided by the manufacturer. Purified mRNAs
from human osteosarcoma cell lines SAOS-2, U2-OS and
from the T/C 28a4 human chondrocytic cell line were
generously provided by Dr Matthew Stewart, Department
of Orthopaedics, Case Western Reserve University,
Cleveland, OH. Approximately 1.5 g of purified mRNA from
primary chondrocytes was used to prepare a complex
cDNA probe labeled with 33P-dCTP (Amersham, Arlington
Heights, IL) for screening the Atlas Human cDNA
Expression Array (Clontech Laboratories Inc., Palo Alto,
CA) according to the manufacturer’s protocol. Image
acquisition and analysis was performed using
Phosphorimager and ImageQuant software (Molecular
Dynamics, Sunnyvale, CA) using the facilities of the Gene
Expression Analysis Core at Case Western Reserve
University School of Medicine.AMPLIFICATION AND SEQUENCING OF PTK mRNAs
Degenerate primers for PCR were based on the con-
served DFG and DVW regions of the tyrosine kinases
sequences and the PCR amplification reaction was per-
formed as described previously16 using ∼10 ng of single
stranded cDNA. Amplified cDNA fragments were electro-
phoretically resolved on 3% NuSieve agarose gel, bands
were excised, purified with a Spin-X cartridge (Costar, New
York) and cloned into TA vector (pGEM-T cloning kit,
Promega, Madison, WI). Automated double-stranded DNA
sequencing of 1000 recombinants was performed using the
ABI Prism 377 Sequencing System. The sequences were
compared with the catalogued nucleotide sequences avail-
able in the GenBank/EMBL DNA database (nr) using the
BLAST algorithms at the National Center for Biotechnology
Information (NCBI). Homologous sequences were retrieved
using the Entrez server of the NCBI.EXPRESSION ANALYSIS OF SELECTED KINASES BY RT-PCR
Purified mRNA from human OA chondrocytes and from
the cell lines (1 g from each) was employed in the reverse
transcriptase reaction using random primers (SuperScript
Preamplification System, GIBCO-BRL). PCR primers and
probes specific for Axl tyrosine kinase, TKT kinase (also
known as Discoidin Domain Receptor Kinase 2 or
DDR2), and DDR1 kinase were designed using the
retrieved sequences from the GenBank/EMBL DNA
Database and the Lasergene Software (DNA Star,
Madison, WI). Expression of erb/B1, erb/B2, erb/B3 andIGF-1 was attributed to an altered signaling pathway13.
Epidermal growth factor (EGF) has been shown to nega-
tively regulate chondrogenesis by modulating the ERK-1
and p38MAPK signaling pathways14. It has also been
shown that IL-1-induced the expression of matrix-
metalloproteinase-13 (MMP-13) and MMP-1 in chondro-
cytes via different signaling cascades involving the p38 and
c-Jun N-terminal kinase (JNK) and p38 and MEK respect-
ively, suggesting that IL-1-induced expression of MMP-1 in
chondrocytes depends on a unique combination of signal-
ing pathways15. These and other studies indicate that a
complex network of signaling molecules involving protein
phosphorylation by different protein kinases may be
involved in maintaining chondrocyte metabolism and func-
tion. However, no data is available documenting the global
expression profile of PTK genes in primary or immortalized
human chondrocytes. To fully understand the chondrocyte
responses in health and disease, it is vital that we are able
to accurately profile the expression of genes and molecules
involved in different signal transduction pathways in
chondrocytes. Thus, profiling the chondrocyte protein
kinases would be valuable in understanding diseases
affecting cartilage homeostasis such as RA and OA and
could also improve our understanding of experimental
cartilage repair models.
In this study, we analysed the expression profile of PKs
and PTKs mRNA in human OA chondrocytes using the
Atlas Human cDNAArray and a method based on PCR with
degenerate primers16. Through this combined approach,
21 receptor and non-receptor type PTK genes were identi-
fied in primary human chondrocytes. Transcripts of several
of these kinases (HCK, DDR2, CCK4) were not previously
shown to be expressed in primary or immortalized human
chondrocytes. We also compared the expression of
selected kinase genes in human OA chondrocytes and in
chondrocyte-like cells HTB-94 and in two osteosarcoma
cell lines by RT-PCR and Western blotting. We found that
the Axl receptor tyrosine kinase gene was over-expressed
in a chondrosarcoma and an osteosarcoma cell line. In
contrast, OA chondrocytes and the T/C 28a4 cells only
showed low level expression of Axl mRNA and protein.
These findings are in agreement with results reported
previously17. Other results showed that DDR2 kinase and
the novel HCK kinase proteins were not expressed in
chondrocytes but were expressed in T/C 28a4 and other
cell lines analysed. Overall, these results show that the
expression pattern of the protein kinases was remarkably
similar, but not identical, in human OA chondrocytes and
the chondrocytic cell line T/C 28a4 and differs from that of
chondrosarcoma and osteosarcoma cells. Thus, these
results indicate that the T/C 28a4 cells may be suitable for
studies designed to elucidate signal transduction path-
ways important in chondrocyte metabolism in health and
disease.
686 S. Islam et al.: Tyrosine kinases of human chondrocytic/bone cellserb/B4 kinases was analysed using the previously
described gene specific primers20. Sequences of the
primer sets used, and the expected sizes of PCR products
are shown in Table I. PCR amplified bands were resolved
by agarose gel electrophoresis and alkaline transferred
to positively charged nylon membrane (Hybond N+,
Amersham) and probed with -P32 (Amersham) labeled
oligonucleotide probe (Table I) specific for a sequence
internal to the PCR primers.WESTERN BLOT ANALYSIS OF SELECTED TYROSINE KINASES
Total cell lysate was prepared in RIPA buffer (1% Nonidet
P-40 in PBS, 0.5% Sodium Deoxycholate, 0.1% SDS) to
which was added Protease Inhibitor Cocktail Tablet
(Boehringer-Mannheim, Indianapolis, IN; 1 Tablet/10 ml of
RIPA buffer). Cells were lysed on ice, passed through a
21-gauge needle 10 times and then centrifuged at
10,000×g for 15 min at 4°C for 10 min and the supernatant
was used for the analysis of protein expression. A total of
20–40 g of cellular lysate was resolved by SDS-PAGE
and transferred to PVDF membranes as previously
described21. Membranes were blocked in Blotto A (sc-
2333, Santa Cruz Biotechnology, Santa Cruz, CA) and then
sequentially probed with primary and HRP-conjugated
secondary antibodies, washed with washing buffer
(Tween-TBS, 10 mM Tric-HCl, pH 8.0; 150 mM NaCl;
0.05% Tween-20) and the proteins visualized by enhanced
chemiluminescence (Amersham). The following polyclonal
primary antibodies (all from Santa Cruz) were used: anti-
Rse (sc-1094); anti-Axl (sc-1096); anti-pERK (sc-7383),
anti-HCK (sc-72), anti-MLK-3 (sc-536) and anti--Actin
(sc-1616). Secondary antibodies (HRP-conjugated) were
purchased commercially (Cell Signaling Technologies,
Beverly, MA).ResultsTable I
Sequences of the PCR primers and probes used for the PTKs expression profiling in human chondrocytes and
cell lines of chondrocytic/bone lineage
Kinase (GB no.) Primer sequence (5′–3′) PCR Product
TKT (X74764) Sense 5′- CTGCAGCGGTGTTGTGAAGC-3′
(DDR2) Anti-Sense 5′-GGCCCTGGATCCGGTAATAGTC-3′ 731 bp
Probe 5′-GTGGCGGGAAAGAAACTGATTGAG-3′
AXL Sense 5-′CTACACAGCTTCCTCCTCTATTCC-3′
(NM
–
001699) Anti-Sense 5′-CTCCCAGCACCGCGACATCAA-3′ 480 bp
Probe 5′-GATATGGGGTTTGGCCTCTTGTGG-3′
DDR1 (L57508) Sense 5′-TCGAGGCTCAAGGACCCAAACATC-3′ 377 bp
(CAK) Anti-Sense 5′-CGGCCCTGCACACGGTAATAGTC-3′
Probe 5′-AGAACGGCGACCTCAACC-3′Table II
Expression of protein kinases in human OA chondrocytes detected
by Atlas Human cDNA Array
GenBank
accession
no.
Description
D17517 Tyrosine-protein kinase receptor ufo (sky)
K03218 Proto-oncogene tyrosine-protein kinase src
M68520 CDC2-related Protein Kinase CLK (CLK3)
X74764 Tyrosine-protein kinase CAK (tyrosine kinase,
receptor TKT)
L32976 Protein kinase MLK-3 (Mixed lineage kinase 1)
U09564 Serine kinase
U09607 Tyrosine-protein kinase JAK1 (Janus kinase3)
M31158 cAMP-Dependent protein kinase type-II 
regulatory chain
M64174 Tyrosine-protein kinase JAK1
M65066 cAMP-Dependent protein kinase type I-
regulatory chain
M84489 ERK2 (Extracellular signal-regulated kinase 2)
U30473 Tyrosine-protein kinase HCK
U09578 Map kinase activated protein kinase (3pk)
U33635 Colon Carcinoma kinase-4 [CCK4]EXPRESSION ANALYSIS OF PROTEIN KINASES IN HUMAN
CHONDROCYTES BY ATLAS cDNA ARRAY AND PCR WITH
DEGENERATE PRIMERS
We first used the human Atlas cDNA expression array to
identify the protein kinases expressed in human OA
chondrocytes. Reverse transcribed mRNA from primary
chondrocytes was used for this analysis. Only the spots
showing more than two-fold difference in the intensity of
hybridization when compared to the intensity of cDNA spots
corresponding to house keeping genes on the array werecounted as positive and scored. Based on this criteria, our
results identified several kinases (Table II), some of which,
e.g. HCK, CCK4 and DDR2 have not previously been
reported to be expressed either in OA chondrocytes or in
cell lines analysed in this study.
Since the bound targets on the array represented only a
limited number of known PTKs, we also used RT-PCR with
degenerate-primers encoding the conserved DFG and
DVW sequences present in PTKs to amplify the conserved
regions in PTKs. The combination of primers used specifi-
cally amplified cDNA fragments ranging in size from 160–
170 bp (data not shown). Sequence analysis of cloned
fragments and a BLAST search of GenBank/EMBL DNA
Database (nr) identified 17 distinct cDNA clones represent-
ing mostly PTKs that were also identified using Atlas
Human cDNA array except for Axl, DDR2 and Lyn B Kinase
(Table III). Identification and cataloging were based on
maximum homology with a corresponding sequence
present in the GenBank/EMBL DNA Database and the
SwissProt Protein Database. Some of the cDNA clones
contained identical sequences while others had unique
sequences but no novel PTKs were identified. As can be
seen (Tables II and III), both the receptor type PTKs (six
cDNAs) and the non-receptor PTKs (two cDNAs) were
identified in these studies. Expression of the dual specificity
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results reported in a previous study from this laboratory
(Ah-Kim et al.18, data not shown). Translated amino acid
sequence of the cDNA clone THSI-2 (Table III) showed a
complete match with the peptide sequence of the platelet
derived growth factor receptor  (PDGFR, sp P09619,
BLAST E value 1e-20) while the translated amino acid
sequence of the cDNA clone THSI-137 was homologous to
the peptide sequence of colony-stimulating factor 1 recep-
tor (CSF-1R, sp P07333, Table II). Other receptor kinases
identified in this study included the long and short isoforms
of the cell adhesion kinase (CAK) DDR1 and DDR2 ( cDNA
clones THSI-130 and THSI-91 respectively, Table III).EXPRESSION ANALYSIS OF SELECTED KINASES BY RT-PCR
Homologous sequences were retrieved and used to
design oligonucleotide primers. These primers were used
to determine the gene expression of selected PTKs in
human chondrocytes and other cell lines of chondrocytic
and bone lineage. Our results show that DDR1 mRNA22
was expressed in primary articular chondrocytes and in all
the cell lines analysed (Fig. 1). Interestingly, in chondro-
cytes a predominant single band was present, while in all
the other cell lines analysed, the DDR1 mRNA appeared as
a doublet (Fig. 1). In contrast, expression of DDR2 was not
detected in either the OA chondrocytes or the T/C 28a4
cells (Fig. 1). Expression of DDR2 kinase was low in the
chondrosarcoma cells HTB-94 but the level of expression
was at least twice in osteosarcoma cells U2-OS when
compared with SAOS-2 cells (Fig. 1). Through cloning and
sequencing we also identified a novel variant of DDR2
kinase (clone THSI-168, Table III) with three amino acid
differences when compared with the publicly available
nucleotide and protein sequences of Tyro 10/DDR2 and
one amino acid difference when compared with the DDR1
sequence (Table III). However, lacking in vitro mutagenesis
and functional analysis it is not yet possible to predict the
effect of these mutations on the function of DDR2 PTK in
these cells.
Primary chondrocytes and the cell lines T/C 28a4, HTB-
94, SAOS-2 and U2-OS were found to express the receptor
kinase Axl (THSI-1) mRNA (Fig. 1). Although out method
was not quantitative it still can be used to estimate relative
levels of gene expression. This analysis indicated that
expression of Axl kinase mRNA was less abundant in
primary chondrocytes and T/C 28a4 cells but washighly expressed in the chondrosarcoma HTB-94 and
osteosarcoma cells (Fig. 1).EXPRESSION PROFILE OF ERBB/EGFR IN ARTICULAR
CHONDROCYTES AND IN T/C 28A4, HTB-94, SAOS-2 AND U2-OS
CELL LINES
Using the previously published PCR primers specific for
erbB family members20 we analysed the expression of
erbB1, erbB2, erbB3 and erbB4 (Fig. 2). All of the samples
tested were found to express erbB1, erbB2 and erbB3 gene
transcripts but the mRNA expression of erbB4 was limited
to the osteosarcoma cells U2-OS.Table III
Putative amino acid sequences of PTK cDNAs isolated using the PCR based method
DFG LARDIMNDSNYIVKGNARLPVK W MAPESIFDCVYTVQSDVW CSF-1R (sp P 07333)
DFG LARDIMNDSNYIVKGNARLPVK W MAPESIFDCVYTVQSDVW THSI-137
DFG LARDIMRDSNYISKGSTFLPLK W MAPESIFNSLYTTLSDVW PDGF-R (sp P09619)
DFG LARDIMRDSNYISKGSTFLPLK W MAPESIFNSLYTTLSDVW THSI-2
DFG MSRNLYAGDYYRVQGRAVLPIR W MAWECILMGKFTTASDVW DDR1 (sp Q 08345)
DFG MSRNLYAGDYYRVQGRAVLPIR W MAWECILMGKFTTASDVW THSI-130
DFG MSRNLYSGDYYR I QGR AVLPIR W M SWESILLGKFTTASDVW DDR2 (sp Q 16832)
DFG MSRNLYSGDYYR I QGR AVLPIR W M SWESILLGKFTTASDVW THSI-91
DFG MSRNLYAGDYYRVQGQ AVLPIR W M SWESILLGKFTTAS DVW THSI-168
DFG LARLIEDNEYTARQGAKFPIK W TAPEAALYGRFTIKSDVW Src Kinase (sp P00523)
DFG LARLIEDNEYTARQGAKFPIK W TAPEAALYGRFTIKSDVW THSI-5
DFG LSKKIYNGDYYRQGRIAKMPVK W IAIESLADRVYTSKSDVW Axl (sp P30530)
DFG LSKKIYNGDYYRQGRIAKMPVK W IAIESLADRVYTSKSDVW THSI-1
Gaps were introduced for maximum alignment. Amino acid differences identified in the sequence of THSI-168
are in bold italics and underlined.EXPRESSION ANALYSIS OF SELECTED PROTEIN KINASES BY
WESTERN BLOTTING
We also determined the protein expression of some of
the kinases by Western blotting and these results are
presented in Fig. 3. Expression of Axl mRNA in human
chondrocytes and the T/C 28a4 cells was readily detected
by RT-PCR (Fig. 1) as previously reported17. Western
blotting also showed low level expression of Axl protein in
both the primary chondrocytes and in the T/C 28a4 cells
[Fig. 3(B)]. However, high levels of Axl protein were found
in the chondrosarcoma HTB-94 cells [Fig. 3(B)]. As Axl has
been shown to possess transforming properties23, the
observed high level expression of Axl protein in HTB-94
cells may be associated with the transformed nature of
these cells.
Other protein tyrosine kinases whose expression was
also determined by Western blotting included ERKp41/p42,
HCK, and Rse (also known as sky, ufo, Tyro3). All of the
samples analysed were found to express the ERK protein
[Fig. 3(A)]. Since the antibodies used were specific for the
phosphorylated ERK (pERK) these results indicated that
ERK was active in these cells. Antibodies used for the
protein expression analysis of HCK cross reacted with
several proteins with relative molecular mass of p100, p90,
p80, p59/p61, p40 and p30 in the chondrocytic and osteo-
genic cell lines [Fig. 3(c)]. The p59/61 are the known
isoforms of HCK24). Additionally, a cross reactive prominent
band of >172 kD was detected in T/C 28a4, SAOS-2,
U2-OS and HTB-94 cells [Fig. 3(c)]. The p40 protein was
detected only in T/C 28a4 and U2-OS cells [Fig. 3(c)]. By
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isoforms were not detected in primary OA chondrocytes
[Fig. 3(c)] but weak expression of p59/p61 HCK isoforms
was detected in T/C 28a4 cells [Fig. 3(c)]. Expression of
MLK-3, which is associated with cell proliferation, was most
abundant in T/C 28a4 and HTB-94 cells but was very low in
OA chondrocytes [Fig. 3(d)] indicating that this pathway
was not constitutively active in OA chondrocytes (at least in
the samples analysed). Protein expression of Rse was not
detected either in the primary chondrocytes or in the cell
lines analysed (results not shown).Fig. 1. Analysis of selected tyrosine kinases gene expression in articular chondrocytes and cell lines of chondrocytic/bone lineage.
Expression pattern of Axl kinase, DDR1 kinase, and DDR2 kinase (Table III) was analysed by RT-PCR. HPRT, a housekeeping gene was
used as a control, both for reverse transcription and PCR. Equal amounts of PCR aliquots were loaded in each lane and the products were
analysed by 2% agarose gel electrophoresis. DNA was transferred to positively charged nylon membranes and probed with 32P labeled
oligonucleotide probes (Table I). Results clearly show that the DDR2 kinase was not expressed in articular chondrocytes. (Lane 1.
Chondrocytes; 2. Chondrocytic Cell Line T/C 28a4; 3. HTB-94; 4. SAOS-2; 5. U2-OS.)Discussion
The Atlas Human cDNA Array and a method employing
RT-PCR with degenerate primers was used to profile
the PKs and PTKs of human chondrocytes, immortalizedchondrocytes and osteogenic cell lines. These techniques
revealed that the PTK profile of human chondrocytes and
that of the immortalized chondrocyte cell line T/C 28a4
were highly similar except for the expression pattern of
tyrosine kinase HCK. However, the PTK profile of human
chondrocytes and T/C 28a4 differed from that of chondro-
sarcoma cell line HTB-94 in several respects. For example,
our results of Western blot analysis showed that HTB-94
cells expressed high levels of the Axl receptor tyrosine
kinase protein whereas primary OA chondrocytes and the
T/C 28a4 cells showed very little expression of Axl receptor
tyrosine kinase protein (Fig. 3). The chondrocytes and the
T/C 28a4 cell line also differed from osteogenic cell lines in
the mRNA expression of erbB4 and Axl PTK genes (Fig. 1).
In addition to PTKs found in chondrocytes and previously
reported in many cells6,7, the present study revealed for the
first time that chondrocytes expressed the novel Src family
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chondrocytes and cell lines of chondrocytic/bone lineage. Equal
amounts of mRNAs from chondrocytes and the cell lines were
used to synthesize single stranded cDNA and subsequent PCR
assisted amplification of erbB family transcripts. All the samples
were found to express erbB1, erbB2, and erbB3 transcripts.
Expression of erbB4 (based on the presence of right size band)
was detected only in U2-OS osteosarcoma cells. (Lane 1.
Chondrocytes; 2. Chondrocytic Cell Line T/C 28a4; 3. HTB-94;
4. SAOS-2; 5. U2-OS.)member HCK25, DDR222 and CCK426 gene transcripts. A
number of the PTKs identified in the human OA chondro-
cytes have significant biological functions which make
future studies of their regulation pertinent to the pathogen-
esis of OA and RA and to the repair of cartilage lesions
employing transplanted chondrocytes.
The PDGFR gene and the CSF-1R gene encode pro-
teins that belong to the same subfamily of receptor PTKs.
Both genes are located on chromosome 5q and are linked
physically in a head-to-tail array with less than 500 bp
between the polyadenylation signal of the PDGFR gene
and the transcription start point of the CSF-1R gene27.
Mutations in the CSF-1R gene can induce constitutive
activation of the kinase activity to provide growth-
stimulatory signals27. The PDGFR exist in two distinct
forms, the  and  and each is coded by a separate gene
(28,29 and references therein). The PDGF isoforms bind
with different affinities to the PDGFR and PDGFR recep-
tors inducing receptor dimerization resulting in receptor
autophosphorylation and kinase activation30. It has been
shown that PDGF in combination with TGF- induce pro-
teoglycan synthesis by articular chondrocytes resulting in
enhanced cartilage matrix production29,31.
The DDR is a type-I membrane protein and member of a
novel family of receptors characterized by the unique
structure of the ectodomains suggesting that DDR may beinvolved in cell-cell interactions and recognition32. Both
DDR1(also known as ptk-3) and DDR2 tyrosine kinases are
widely expressed in fetal and adult tissues and expression
of DDR1 kinase is rapidly induced by ionizing radiation33.
DDR2 was originally cloned from brain but is now known to
be expressed in connective tissue34. Normally DDR1 is
expressed at low levels in most adult tissues but is abun-
dantly expressed in breast carcinoma and is up-regulated
by p53 protein and also by collagen type I, II, III, V, XI34,35
while DDR2 is activated mainly by collagen types I and
III34. Employing RT-PCR with highly specific primers,
expression of DDR2 kinase was not detected in human OA
chondrocytes and the T/C 28a4 cells in the present study
but was readily detected in the other cell lines analysed
including HTB-94 (Fig. 2). This suggests that the signal
detected on the Atlas cDNA Array (Table II) may be due to
cross-hybridization of the spot containing DDR2 kinase
cDNA with the DDR1 kinase transcripts (DDR1 found to be
expressed in chondrocytes, Fig. 1), with which it shares
77–81% regional homology at the nucleotide level. In
the present study, the cell line SAOS-2 constitutively
expressed both DDR1 and DDR2 genes, although these
cell lines do not synthesize type-II collagen (results not
shown). The DDR promoter contains a p53 consensus
sequence binding site and adenovirus mediated p53
expression in SAOS-2 transfectants resulted in over-
expression of DDR mRNA implicating p53 in regulating
DDR expression35. The OA chondrocytes used in the
present study did not express high levels of p53 (unpub-
lished data) but were found to express DDR1 kinase mRNA
(Fig. 1), indicating that the expression of DDR1 kinase in
chondrocytes may be independent of the level of p53 gene
expression. However, by Western blot analysis we were not
able to detect the DDR1 protein either in chondrocytes or in
cell lines tested (results not shown) indicating that either
the mRNA was not translated or the protein was not stable
in the cells analysed. Future investigations may help to
differentiate between these possibilities.
Axl adhesion kinase and its ligand, the growth-arrest
specific gene 6 (Gas-6), have both been shown to be
expressed in human cartilage and chondrocytes and in T/C
28a4 cells17 but not in other cell lines analysed in this study.
Axl kinase has been shown to have a transforming
activity24 and its over-expression in chondrosarcoma and
osteosarcoma cell lines (Fig. 3) may be associated with
their immortalized phenotype. Gas-6, the ligand of Axl, is a
gamma-carboxyglutamic acid (Gla)-containing protein and
its expression has been shown to correlate with the
increased survival of chondrocytes in serum-free medium
supporting the conclusion that Gas-6 and Axl PTK repre-
sent an autocrine signaling pathway in cartilage and may
play an important role in the control of chondrocyte growth
and survival17. In agreement with these previously reported
results, expression of Axl mRNA (Fig. 1) and Gas-6 mRNA
(results not shown) was detected in human OA chondro-
cytes and the T/C 28a4 cell line. Additionally, our results
also showed that the Axl protein was abundantly expressed
in the chondrosarcoma cell line HTB-94 (Fig. 3) suggesting
that this could be related to the transformed nature of
HTB-94 cells. Expression of Gas-6 protein in the chondro-
cytes has been reported to be up-regulated by the stimu-
latory signals provided by cytokines and growth factors17.
Since in the present studies chondrocytes or the cell lines
were not treated with cytokines or growth factors in vitro
prior to analysis, expression of Gas-6 protein was not
detected on a Western blot (results not shown).
690 S. Islam et al.: Tyrosine kinases of human chondrocytic/bone cellsFig. 3. Protein expression analysis of selected PKs in primary human OA chondrocytes and cell lines of chondrocytic/bone lineage.
Cells were lysed in lysis buffer and 20–40 g of protein/lane was resolved by SDS-PAGE and transferred to PVDF membranes. The Western
blots were blocked and probed with polyclonal antibodies to the indicated proteins and the proteins were visualized by enhanced
chemiluminescence. To verify equal protein transfer, blots were stripped and reprobed with antibodies to human -Actin.Expression of CLK3 mRNA (also called Cdk2) was also
detected in human chondrocytes (Table II). This kinase was
originally cloned by complementation studies36 and is now
known to be involved in cell cycle regulation. In the cell,
Cdk2 specifically associates with the cyclin E, which is the
predominant cyclin during G1 phase of the cell cycle, and
high level expression of Cdk2 and cyclin E has been
reported in various malignant cell types36,37. Although a
hallmark of cycling cells, expression of Cdk2 in association
with cyclin E has also been shown in chondrocytes38.
However, what role the Cdk2/cyclin E complex may play inchondrocytes in vivo where chondrocytes are thought to be
non-cycling, differentiated cells, is not clear.
The ERK gene was also found to be expressed in
primary chondrocytes (Table II) and by Western blotting
active ERK protein was also detected in the chondrocytes
and the cell lines analysed (Fig. 3). The mitogen-activated
protein kinase/extracellular signal regulated kinase (MAPK/
ERK) play an important role in signaling cascade and are
stimulated by cytokines and receptor tyrosine kinases39.
Both p44 and p42 MAP serine threonine kinases (ERK 1
and ERK 2) are phosphorylated at tyrosine residues by
Osteoarthritis and Cartilage Vol. 9, No. 8 691upstream tyrosine kinases and function in a protein kinase
cascade that plays a critical role in the regulation of cell
growth and differentiation39. Activated p44/p42 MAP kinase
phosphorylates key enzymes and translocates to the
nucleus where it activates transcription through the c-myc
and Elk1 transcription factors39. It has been recently shown
that ERK1/2 may be directly activated by TNF-R1 bypass-
ing neutral sphingomyelinase and c-Raf-1 suggesting that
ERK1/2 may be playing a more assertive role in the
generation of proinflammatory eicosanoids than previously
thought40. Since the antibodies used were phosphory-
lation state specific, our results suggest that ERK was
constitutively active in primary OA chondrocytes.
The Src family kinases are involved in the modulation of
different signal transduction pathways associated with cell–
cell or cell–matrix adhesions, cellular growth and differen-
tiation5,41. So far nine members of the Src kinase family
have been identified in vertebrates and their expression
pattern varies in different cell types. Members of the Src
family also are critical for signal transduction in response to
cell-cell or cell-matrix adhesion7,42. Activity of Src kinase
has been shown to be associated with matrix mineralization
and production of type X collagen by chondrocytes43. This
suggests an important role of src-kinases in the context of
cartilage homeostasis as degradation of cartilage matrix in
an arthritic joint could also modulate cell density and trigger
chondrocyte apoptosis44 thereby accelerating the loss of
cartilage and joint function in both RA and OA. Additionally,
the disparity observed in the expression of erbB4 mRNA
could be important in understanding the pathophysiology
and progression of different osteosarcoma/malignancies.
The erbB3 receptor (expressed in all the samples
tested) lacks any intrinsic kinase activity but can pair with
erbB1 and erbB2 and diversify the kinase signal (6,16 and
references therein).
Human chondrocytes were also found to express the
transcripts of the novel src-family kinase HCK (also known
as receptor type protein tyrosine kinase 7 or PTK7) which
was first isolated using a RT-PCR based screening method
from human melanocytes45. HCK tyrosine kinase is a
member of Src gene family of receptor tyrosine kinases and
was found to be expressed predominantly in B cells and
cells of myeloid lineage24,25. The two isoforms of HCK, p61
and p59, have been described and arise by alternative
translation making HCK unique among the Src family of
PTKs. The p59 isoform is mainly associated with plasma
membrane and p61 isoform with lysosomes suggesting a
role for HCK in a signaling pathway leading to granule–
plasma membrane fusion24. The transmembrane portion of
the HCK protein was found to contain several substitutions
within the consensus RTK sequence leading to the sugges-
tion that HCK may be a catalytically inactive member of the
RTK family. However, recent studies have provided evi-
dence that HCK can undergo autophosphorylation at two
sites—Tyr-388 and Tyr-29—one of which (Tyr-29) is
located in the unique domain of HCK which identifies a new
mechanism for the regulation of Src-family tyrosine
kinases24. To our knowledge, expression of HCK mRNA or
the protein has not been previously shown in the cell lines
analysed in this study. By Western blot analysis, HCK
protein was not detected in primary OA chondrocytes
indicating that the HCK mRNA was not translated or the
translated protein was not stable in these cells. As the
function or role of HCK in signal transduction is not yet
established, it is difficult to suggest the implications of the
absence of HCK protein in chondrocytes.In summary, we provide novel information regarding the
global expression profile of receptor and non-receptor type
PTKs in human OA chondrocytes and in an immortalized
chondrocyte cell line. We also compared the pattern
obtained with that of chondrocyte-like cells and cell lines of
bone lineage. Variable mRNA and protein expression of
PTKs Axl, HCK, and erbB4 in chondrocytes and the cell
lines analysed, as well as the overall PTK gene expression
profile presented here, should be important in designing
future studies to probe the effects of cytokines and growth
factors on these PTKs with the goal of understanding their
role in the pathogenesis of diseases affecting cartilage and
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